Working… Menu

AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. (AURORA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02102165
Recruitment Status : Recruiting
First Posted : April 2, 2014
Last Update Posted : March 22, 2018
Breast European Adjuvant Studies Team
Frontier Science & Technology Research Foundation, Inc.
Information provided by (Responsible Party):
Breast International Group

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : January 2029